(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.47%) $78.48
(1.87%) $2.18
(0.07%) $2 310.30
(0.52%) $26.83
(0.13%) $966.60
(-0.36%) $0.929
(-1.33%) $10.85
(-0.13%) $0.797
(0.52%) $91.61
3.98% $ 2.09
Live Chart Being Loaded With Signals
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound...
Stats | |
---|---|
Dzisiejszy wolumen | 710 672 |
Średni wolumen | 1.70M |
Kapitalizacja rynkowa | 1.44B |
EPS | $0 ( 2024-02-26 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -209.00 |
ATR14 | $0.00300 (0.14%) |
Wolumen Korelacja
Polynovo Ltd Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Polynovo Ltd Korelacja - Waluta/Towar
Polynovo Ltd Finanse
Annual | 2023 |
Przychody: | $65.24M |
Zysk brutto: | $19.33M (29.63 %) |
EPS: | $-0.00720 |
FY | 2023 |
Przychody: | $65.24M |
Zysk brutto: | $19.33M (29.63 %) |
EPS: | $-0.00720 |
FY | 2022 |
Przychody: | $41.44M |
Zysk brutto: | $16.23M (39.16 %) |
EPS: | $-0.00180 |
FY | 2021 |
Przychody: | $29.16M |
Zysk brutto: | $27.60M (94.67 %) |
EPS: | $-0.00690 |
Financial Reports:
No articles found.
Polynovo Ltd
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej